You have 8 free searches left this month | for more free features.

Polymorphous low-grade neuroepithelial tumor of the young

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,

Not yet recruiting
  • Anaplastic Astrocytoma
  • +17 more
    • (no location specified)
    Jun 28, 2023

    Recurrent World Health Organization (WHO) Grade II Glioma Trial in United States (Everolimus, Trametinib)

    Recruiting
    • Recurrent World Health Organization (WHO) Grade II Glioma
    • Birmingham, Alabama
    • +11 more
    May 6, 2022

    Low-Grade Glioma, Recurrent Low-Grade Glioma, Progressive Low-Grade Glioma Trial in Memphis (Mirdametinib)

    Recruiting
    • Low-Grade Glioma
    • +2 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Oct 24, 2022

    Low-grade Glioma, Advanced Solid Tumor Trial in Worldwide (DAY101)

    Recruiting
    • Low-grade Glioma
    • Advanced Solid Tumor
    • San Francisco, California
    • +35 more
    May 25, 2022

    MVNT (Multinodular and Vacuolating Neuronal Tumor)

    Recruiting
    • Benign Neuronal Desease
    • cerebral MRI
    • Bordeaux, France
    • +6 more
    Mar 18, 2022

    Rare Embryonal Tumors of Central Nervous System: International

    Not yet recruiting
    • Embryonal Tumor
      • Yerevan, Armenia
        Hematology Center named after prof. R. Yeolyan
      Jan 25, 2023

      NF1, Low-grade Glioma Trial in United States (Poly ICLC)

      Recruiting
      • NF1
      • Low-grade Glioma
      • Poly ICLC
      • Birmingham, Alabama
      • +18 more
      Jan 5, 2023

      Brain Tumors Trial in San Diego, Atlanta (Poly ICLC)

      Completed
      • Brain Tumors
      • Poly ICLC
      • San Diego, California
      • +1 more
      Apr 20, 2022

      Stored Tumor Samples in Young Patients With Brain Tumors

      Recruiting
      • Brain and Central Nervous System Tumors
        • Memphis, Tennessee
          St. Jude Children's Research Hospital
        Apr 5, 2022

        Frameshift Peptides of Children With NF1

        Completed
        • Neurofibromatosis Type 1
        • Frameshift Array blood sample test
        • Washington, District of Columbia
        • +2 more
        Aug 29, 2022

        Glioma, High Grade Glioma, Glioma, Malignant Trial in Philadelphia (18F-Fluciclovine PET-MRI)

        Recruiting
        • Glioma
        • +4 more
        • 18F-Fluciclovine PET-MRI
        • Philadelphia, Pennsylvania
          Children's Hospital of Philadelphia
        Dec 22, 2022

        Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)

        Active, not recruiting
        • Brain and Central Nervous System Tumors
        • Induction Chemotherapy
        • +3 more
        • Palo Alto, California
        • +5 more
        Nov 29, 2022

        The Immune Landscape of Epithelial Ovarian Cancer

        Recruiting
        • Epithelial Ovarian Cancer
        • Collection of tumor samples, blood and vaginal and rectal swabs
        • Bellinzona, Switzerland
          Oncology Institute of Southern Switzerland
        Aug 2, 2023

        Glioma, Low-grade Glioma, Low Grade Glioma of Brain Trial in Philadelphia (18F-Fluciclovine)

        Not yet recruiting
        • Glioma
        • +4 more
        • Philadelphia, Pennsylvania
          Children's Hospital of Philadelphia
        Oct 3, 2022

        Recurrent Low Grade Astrocytoma, Recurrent WHO Grade 2 Glioma, Refractory Low Grade Astrocytoma Trial in Canada, United States

        Recruiting
        • Recurrent Low Grade Astrocytoma
        • +4 more
        • Quality-of-Life Assessment
        • +3 more
        • Birmingham, Alabama
        • +64 more
        Aug 20, 2022

        5-Aminolevulinic Acid Gliolan®: Usage Increase Proposal for

        Not yet recruiting
        • High Grade Glioma
        • +10 more
        • 5-Aminolevulinic Acid (5-ALA) Gliolan®
        • Fluorescence-Guided Surgery using 5-aminolevulinic acid (5-ALA)
        • Guayaquil, Guayas, Ecuador
          Sociedad de Lucha Contra el Cáncer
        Apr 28, 2023

        Targeted Pediatric High-Grade Glioma Therapy

        Not yet recruiting
        • High Grade Glioma
        • +8 more
          • Aurora, Colorado
          • +17 more
          May 1, 2023

          Low Grade Glioma (LGG) of Brain With BRAF Aberration, High Grade Glioma (HGG) of the Brain With BRAF Aberration, Low Grade

          Recruiting
          • Low Grade Glioma (LGG) of Brain With BRAF Aberration
          • +2 more
          • Phoenix, Arizona
          • +12 more
          Apr 7, 2022

          Low-grade Oral Dysplasia Trial in Boston (Probiotic oral lozenges, Standard of care for oral dysplasia)

          Not yet recruiting
          • Low-grade Oral Dysplasia
          • Probiotic oral lozenges
          • Standard of care for oral dysplasia
          • Boston, Massachusetts
            Boston Medical Center
          Jan 22, 2023

          Brain Cancer Trial in Canada, United States (cetuximab in conjunction with external beam radiation therapy, followed by

          Completed
          • Brain Cancer
          • cetuximab in conjunction with external beam radiation therapy, followed by cetuximab and irinotecan
          • Phoenix, Arizona
          • +11 more
          Mar 2, 2022

          Low Grade Glioma Trial in Heidelberg (model-guided optimization of treatment plan, standard treatment plan, no optimization)

          Not yet recruiting
          • Low Grade Glioma
          • model-guided optimization of treatment plan
          • standard treatment plan, no optimization
          • Heidelberg, Germany
            Department of Radiotherapy, University of Heidelberg
          Jul 19, 2023

          CNS Tumors, Medulloblastoma Trial in Worldwide (Pomalidomide)

          Active, not recruiting
          • Central Nervous System Neoplasms
          • Medulloblastoma
          • Stanford, California
          • +24 more
          Sep 28, 2022

          Low Rectal Cancer Trial in Hanzhou (Modified short-course radiotherapy, PD-1 antibody, Capecitabine)

          Not yet recruiting
          • Low Rectal Cancer
          • Modified short-course radiotherapy
          • +3 more
          • Hanzhou, Zhejiang, China
            Sir Run Run Shao hospital
          Jul 31, 2023